- £1.31bn
- £1.20bn
- £374.81m
- 96
- 20
- 57
- 61
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 151 | 179 | 235 | 303 | 375 |
Cost of Revenue | |||||
Gross Profit | 69.1 | 84 | 118 | 140 | 177 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 130 | 156 | 184 | 257 | 322 |
Operating Profit | 21 | 22.8 | 50.3 | 46 | 52.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 21.1 | 23.1 | 50.3 | 46 | 54.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16.9 | 18.6 | 39.6 | 35.8 | 41.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 16.9 | 18.6 | 39.6 | 35.8 | 41.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16.9 | 18.6 | 39.6 | 35.8 | 41.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.139 | 0.153 | 0.335 | 0.296 | 0.332 |
Dividends per Share | |||||
Special Dividends per Share |